Funding for medical device businesses in South Africa

Medical device businesses in South Africa raise against a regulatory reality: SAHPRA licensing governs the market, and the funding route depends on the model — import/distribution, local manufacture, or device development. Distribution businesses raise working capital against hospital-group receivables; manufacturers raise capex and growth equity; developers raise venture capital against clinical and regulatory milestones. Caban has executed more than 200 M&A, capital raising, advisory and turnaround transactions since 2012, and reviews every enquiry through a principal, answered within five working days.

200+transactions since 2012Principalreviews every enquiry5 daysanswer guarantee

Three models, three completely different raises

An importer-distributor is a working-capital business: stock funding and receivables finance against hospital groups and provincial tenders, where payment terms — not demand — are the constraint. A local manufacturer raises capex plus growth equity, with localisation policy and export potential strengthening the case. A device developer is a venture raise: capital against SAHPRA and CE/FDA milestones, clinical evidence, and a credible route to market that usually runs through the distributors.

What funders weigh in South African healthcare

Healthcare is one of Caban’s deepest sectors — the group’s recent transactions include a R160m healthcare raise — and device businesses are assessed on the same fundamentals: quality of the customer base (private hospital groups versus tender dependence), margin durability against currency movement on imported components, and regulatory standing. SAHPRA licence status is diligence item one; treat it that way in the raise.

How Caban helps

Matching the raise to the model — working-capital and bridging structures for distributors, growth equity and mezzanine for manufacturers, venture capital for developers — and reaching the healthcare investor base locally and internationally.

Questions, answered

How do medical device companies get funding in South Africa?

By model: importer-distributors raise working capital against stock and hospital receivables; manufacturers raise capex and growth equity; device developers raise venture capital against SAHPRA/CE/FDA milestones and clinical evidence.

Does SAHPRA licensing matter to investors?

It is the first diligence item. Licence status, the regulatory pathway for new devices, and quality-management certification determine whether a device business is fundable at all — investors price regulatory risk before commercial risk.

Who invests in South African healthcare businesses?

Specialist healthcare PE and VC, the corporate arms of hospital and pharma groups, DFIs with health mandates, and international healthcare investors — a base Caban works with directly; healthcare is among the group’s largest recent transaction sectors.

Go deeper:All funding routes →Growth funding →Corporate finance advisory →All sectors →